Recently published research from the Complutense University of Madrid showed that contrast sensitivity (CS) testing, as measured by the VectorVision CSV-1000, detected early vision loss in patients with mild Alzheimer’s. The researchers tested 26 Alzheimer’s patients and 28 age-matched normal subjects for visual acuity, color vision, contrast sensitivity and ocular coherence tomography (OCT). Results showed patients had …

VectorVision Inc. will be exhibiting at the upcoming ASCRS meeting in New Orleans, LA. This is the first time that ASCRS has been in New Orleans and provides an opportunity for VectorVision CEO Dr. David Evans to get back to his hometown (which he especially appreciates during crawfish and softshell crab season). ASCRS members in attendance …